SEATTLE --An Amgen Inc. spokeswoman confirms that the drugmaker is cutting 100 jobs at its clinical drug manufacturing site in the Seattle suburb of Bothell, Wash.
Carol Pawlak says the cutbacks are not part of any larger companywide reductions. The biotechnology company has 17,000 employees worldwide.
Pawlak said Thursday the company is merging clinical drug trial work at its Bothell facility with operations at its company headquarters in Thousand Oaks, Calif.
She says laid-off employees can reapply for other positions within the company.
Xconomy, a business and technology news site that reported the job cuts, says the cutbacks leave about 70 employees in Bothell, and nearly 900 in Washington state. Pawlak confirms those figures
No comments:
Post a Comment